About fezolinetant
Class: | Non-hormonal treatment for menopausal symptoms (specifically, a neurokinin-3 receptor antagonist)
Use: | Treatment of moderate to severe vasomotor symptoms associated with menopause
Adult dose: | 45 mg orally once daily
Pediatric dose: | Not applicable (not approved for pediatric use)
Side effects: | Hot flashes, nausea, fatigue, headache, diarrhea
Contraindications: | Hypersensitivity to fezolinetant or any component of the formulation; severe hepatic impairment
Storage: |
Drug Class
Non-hormonal treatment for menopausal symptoms (specifically, a neurokinin-3 receptor antagonist)
Uses & Indications
Treatment of moderate to severe vasomotor symptoms associated with menopause
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Astellas Pharma Australia Pty Ltd, Australia
Package Size
30's
Price & Supplier
Price in UAE: AED 11556.00
Dosage Information
Adult Dose
45 mg orally once daily
Pediatric Dose
Not applicable (not approved for pediatric use)
Side Effects
Hot flashes, nausea, fatigue, headache, diarrhea
Contraindications & Precautions
Hypersensitivity to fezolinetant or any component of the formulation; severe hepatic impairment
Important Warnings
Risk of hypersensitivity reactions; monitor for signs of liver dysfunction; not recommended for use in patients with severe liver impairment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.